SCHEMBL208131

SCHEMBL208131

CN(C)C1CCC(N)(Cc2cccc(Cl)c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.43
AKT2 P31751 1/20 0.42
TAAR1 Q96RJ0 2/20 0.42
PNMT P11086 2/20 0.40
MAOB P27338 2/20 0.40
MAOA P21397 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KDM1A O60341 1/20 0.39
RCOR1 Q9UKL0 1/20 0.39
HTR6 P50406 1/20 0.38
SSTR1 P30872 1/20 0.38
SSTR4 P31391 1/20 0.38
PYCR1 P32322 1/20 0.38
CYP3A4 P08684 2/20 0.37
IDO1 P14902 2/20 0.37
AGXT P21549 2/20 0.37
HSD11B1 P28845 1/20 0.37
HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6430626 0.82 AKT2 (0.46) AKT2TAAR1PNMTMAOBMAOA
SCHEMBL205962 0.82 MAOA (0.61) MAOBMAOASLC6A4KDM1ARCOR1
SCHEMBL2473095 0.82 MAOA (0.59) AOC3AKT2TAAR1PNMTMAOB
Hydrochloric Acid SCHEMBL21879608 0.80 MAOB (0.57) AOC3AKT2TAAR1PNMTMAOB
SCHEMBL9667972 0.79 SLC6A4 (0.50) AOC3AKT2TAAR1PNMTMAOB
SCHEMBL5218251 0.79 PNMT (0.50) AOC3AKT2TAAR1PNMTMAOB
SCHEMBL12585406 0.75 AKT2 (0.49) AKT2TAAR1PNMTMAOBMAOA
Formic Acid SCHEMBL6207884 0.74 MAOA (0.49) AKT2TAAR1PNMTMAOBMAOA
SCHEMBL208130 0.73 AOC3 (0.44) AOC3TAAR1PNMTSLC6A2SLC6A4
SCHEMBL13504118 0.71 TAAR1 (0.44) AOC3TAAR1PNMTSLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD AOC3 733/4885AKT2 4088/4885TAAR1 2349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.